Company intelligence / Profile preview

FNApath

Ownership: Private
Development stage: Other

Overview

FNApath was a diagnostics company specializing in Fine Needle Aspiration (FNA) diagnostics, founded by Dr. Nicole Massoll. It partnered with Rosetta Genomics in 2015 for centralized laboratory services. The company appears to be defunct or integrated into another entity, with no active operational website.

Industry: Pathology

Partnerships

Rosetta Genomics

Beyond the preview

Go deeper on FNApath.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FNApath.

Explore the full profile